|
| Press Releases |
|
 |
|
| Friday, October 30, 2020 |
|
|
Avance Clinical Wins MasterControl 2020 Innovation Excellence Award |
| The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical today accepted the MasterControl 2020 Innovation Excellence Award in a virtual ceremony. more info >> |
|
| Wednesday, October 28, 2020 |
|
|
Biotechs get scalable early to late phase clinical offering from Avance Clinical and Cromos Pharma - announced at Bio-Europe 2020 |
| Two dominant regional contract research organizations (CRO), Avance Clinical and Cromos Pharma, with operations in Australia and Central/Eastern Europe, respectively, are successfully collaborating on a scalable clinical solution for biotechs. more info >> |
|
| Tuesday, September 22, 2020 |
|
|
아방스 클리니컬, 바이오팜 아메리카에서 생명공학 임상시험을 위한 전자임상시험 솔루션 확대 발표 |
| 호주의 앞서가는 생명공학 임상시험수탁기관(CRO)이자 프로스트&설리번(Frost & Sullivan)이 수여하는 2020년 아시아태평양 CRO 마켓 리더십 어워드(2020 Asia-Pacific CRO Market Leadership Award)를 수상한 아방스 클리니컬(Avance Clinical)은 개선된 환자 참여, 가시성, 데이터 수집, 분석 등 선진 디지털 임상 수단을 통해 전자임상시험 솔루션(eClinical Solution) 서비스를 확장하고 있다. www.avancecro.com/eclinical-solutions more info >> |
|
|
Avance Clinical宣佈為美國BioPharm的生物技術臨床試驗研究 擴大電子臨床解決方案 |
| 澳大利亞領先的生物技術CRO以及Frost＆Sullivan 2020年亞太CRO市場領導獎的獲得者，Avance Clinical擴展了其電子臨床解決方案產品，提供了先進的數字臨床工具以增強患者參與度，可視性，數據收集和分析。 www.avancecro.com/eclinical-solutions more info >> |
|
|
Avance Clinical宣布为美国BioPharm的生物技术临床试验研究 扩大电子临床解决方案 |
澳大利亚领先的生物技术CRO以及Frost＆Sullivan 2020年亚太CRO市场领导奖的获得者，Avance Clinical扩展了其电子临床解决方案产品，提供了先进的数字临床工具以增强患者参与度，可视性，数据收集和分析。 www.avancecro.com/eclinical-solutions
more info >> |
|
|
Avance Clinical Announces Expanded eClinical Solutions for Biotech Clinical Trials at BioPharm America |
| The leading Australian CRO for biotechs, and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner, Avance Clinical has expanded its eClinical solutions offering, with advanced digital clinical tools for enhanced patient engagement, visibility, data capture, and analysis. www.avancecro.com/eclinical-solutions more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Honda、2026年1月度 四輪車 生産・販売・輸出実績を発表
Feb 26, 2026 15:15: JST
|
|
|
Everest Medicines Shareholders Pass Resolutions Including Commercialization Service Agreement at EGM
Feb 26, 2026 15:27 JST
|
|
|
Champion REIT Delivers Resilient Performance, Proactive Tenant Mix Optimisation Drives Sustainable Development
Feb 26, 2026 14:23 HKT/SGT
|
|
|
トヨタ、2026年1月 販売・生産・輸出実績を発表
Feb 26, 2026 13:30: JST
|
|
|
盈利規模與質量雙升 綠茶集團2025年逆勢交出高分答卷
Feb 26, 2026 12:38 HKT/SGT
|
|
|
盈利规模与质量双升 绿茶集团2025年逆势交出高分答卷
Feb 26, 2026 12:28 HKT/SGT
|
|
|
Mint Delivers First FLOKI Minibot M1 Prototype, Introducing a New AI-Powered Companion for the Asia Pacific Market
Feb 26, 2026 12:05 HKT/SGT
|
|
|
Mint交付FLOKI Minibot M1首個原型機 於亞太市場推出全新AI陪伴機械人
Feb 26, 2026 11:54 HKT/SGT
|
|
|
Mint交付FLOKI Minibot M1首个原型机 于亚太市场推出全新AI陪伴机械人
Feb 26, 2026 11:33 HKT/SGT
|
|
|
Doubleview Gold Corp. 報告截至 2026 年 2 月 25 日更新的礦產資源估算，包括銅當量礦產資源：經測定及指示資源量為 6.09 億噸（Mt），銅當量品位為 0.43% CuEq，含銅當量金屬量 58.2 億磅（CuEq）；推斷資源量為 5.03 億噸（Mt），銅當量品位為 0.41% CuEq，含銅當量金屬量 45.7 億磅（CuEq）
Feb 26, 2026 10:00 HKT/SGT
|
|
|
Doubleview Gold Corp. 报告截至 2026 年 2 月 25 日更新的矿产资源估算，包括铜当量矿产资源：经测定及指示资源量为 6.09 亿吨（Mt），铜当量品位为 0.43% CuEq，含铜当量金属量 58.2 亿磅（CuEq）；推断资源量为 5.03 亿吨（Mt），铜当量品位为 0.41% CuEq，含铜当量金属量 45.7 亿磅（CuEq）
Feb 26, 2026 10:00 HKT/SGT
|
|
|
冠君產業信託於挑戰中彰顯韌性 積極優化租戶組合推動持續發展
Feb 26, 2026 09:50 HKT/SGT
|
|
|
Executive Agility & DealMaker Launch Strategic Collaboration to Power Digital Capital Raising for IPO Readiness
Feb 26, 2026 02:59 HKT/SGT
|
|
|
analytica Hanoi 2026 Makes Its Debut, Bringing the Global Science and Laboratory Platform to Northern Vietnam
Feb 26, 2026 02:52: JST
|
|
|
雲頂新耀股東特別大會通過商業化服務協議等決議案
Feb 25, 2026 20:59 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
